Factor Xa Inhibitors

Products Direct factor Xa inhibitors are commercially available in the form of film-coated tablets and capsules. In 2008, rivaroxaban (Xarelto) was the first agent in this group to be approved in many countries and in the EU. Today, there are other drugs on the market, which are listed below. Like thrombin inhibitors, these active ingredients … Factor Xa Inhibitors

What should be observed when weaning Xarelto®?

Introduction Xarelto® is a trade name for the active ingredient rivaroxaban. This is an anticoagulation drug, colloquially a blood thinner. The family doctor treating you will closely monitor your intake and should not stop taking it without his instructions. However, discontinuation of Xarelto® is necessary under certain circumstances. This should also only be done on … What should be observed when weaning Xarelto®?

Is bridging necessary? | What should be observed when weaning Xarelto®?

Is bridging necessary? Bridging is the interruption of the intake of medication for a short period of time. This may be necessary with anticoagulants before operations. Small operations, such as dental surgery, can be performed without bridging. Larger operations, however, are associated with a high risk of bleeding and therefore cannot be carried out while … Is bridging necessary? | What should be observed when weaning Xarelto®?